Related Experiment Video
Updated: Jan 24, 2026

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
Published on: February 9, 2021
Calcium-binding nanoparticles for vascular disease
Deborah D Chin1, Sampreeti Chowdhuri1, Eun Ji Chung1,2,3,4,5,6
1Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, USA.
Insights
Cardiovascular disease (CVD) involves calcified plaques in blood vessels, increasing rupture risk. Novel nanoparticles offer advanced imaging to detect vascular calcification and plaque composition, improving diagnostics for atherosclerosis.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Nanotechnology
Background:
- Cardiovascular disease (CVD) is a leading global cause of mortality.
- Atherosclerosis involves plaque calcification, linked to plaque rupture and acute myocardial infarction.
- Current imaging techniques for vascular calcification lack detail on plaque composition and structure.
Purpose of the Study:
- To review the role of calcification in atherosclerosis and plaque instability.
- To summarize current clinical methods for detecting vascular calcification.
- To highlight the potential of nanoparticles for improved calcium detection.
Main Methods:
- Literature review of calcification in atherosclerosis.
- Analysis of current clinical imaging modalities.
- Exploration of nanoparticle-based imaging strategies.
Main Results:
- Vascular calcification is a critical factor in atherosclerotic plaque instability.
- Existing imaging methods have limitations in assessing plaque composition.
- Nanoparticles offer a versatile platform for targeted imaging agents.
Conclusions:
- Nanoparticles can overcome limitations of current imaging methods for vascular calcification.
- Calcium-targeting ligands and nanoparticles show promise for novel diagnostic tools.
- Advanced nanoparticle-based imaging could improve the understanding and management of atherosclerosis.
Abstract:
Cardiovascular disease (CVD) including atherosclerosis is the leading cause of death worldwide. As CVDs and atherosclerosis develop, plaques begin to form in the blood vessels and become calcified. Calcification within the vasculature and atherosclerotic plaques have been correlated with rupture and consequently, acute myocardial infarction. However, current imaging methods to identify vascular calcification have limitations in determining plaque composition and structure. Nanoparticles can overcome these limitations due to their versatility and ability to incorporate a wide range of targeting and contrast agents. In this review, we summarize the current understanding of calcification in atherosclerosis, their role in instigating plaque instability, and clinical methodologies to detect and analyze vascular calcification. In addition, we highlight the potential of calcium-targeting ligands and nanoparticles to create novel calcium-detecting tools.
Related Concept Videos
The Equilibrium Binding Constant and Binding Strength
The Equilibrium Binding Constant and Binding Strength
Seedless Vascular Plants
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Ligand Binding and Linkage

